ArticleJournal for immunotherapy of cancer2019

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia.

Melanie Märklin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.